| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008843707 |
| P356 | DOI | 10.1007/S12035-014-8733-6 |
| P698 | PubMed publication ID | 24826919 |
| P2093 | author name string | Vishal Jindal | |
| P2860 | cites work | Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group | Q77436645 |
| Pupillary cholinergic hypersensitivity predicts cognitive decline in community dwelling elders | Q79374029 | ||
| High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease | Q82967333 | ||
| The potential role of amyloid beta in the pathogenesis of age-related macular degeneration | Q24532130 | ||
| Targeting amyloid-beta in glaucoma treatment. | Q24681763 | ||
| Complement factor H polymorphism and age-related macular degeneration | Q29614931 | ||
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| Alzheimer's disease | Q29616743 | ||
| Optical coherence tomography | Q29617481 | ||
| Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease | Q29617986 | ||
| Experimental glaucoma in primates: changes in cytochrome oxidase blobs in V1 cortex. | Q30649727 | ||
| Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease | Q30725675 | ||
| Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration | Q30832375 | ||
| Glaucoma in primates: cytochrome oxidase reactivity in parvo- and magnocellular pathways | Q30877294 | ||
| Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. | Q32069601 | ||
| Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging | Q33264775 | ||
| Retinotopic organization of primary visual cortex in glaucoma: a method for comparing cortical function with damage to the optic disk | Q33270260 | ||
| Retinal abnormalities in early Alzheimer's disease | Q33282836 | ||
| Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of Macrophages | Q33722131 | ||
| Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease | Q33899675 | ||
| The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration | Q34154466 | ||
| Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease | Q34470190 | ||
| Complement activation and inflammatory processes in Drusen formation and age related macular degeneration | Q34521109 | ||
| Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins | Q34750660 | ||
| A new view of diabetic retinopathy: a neurodegenerative disease of the eye. | Q35092253 | ||
| Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma | Q35125723 | ||
| Visual dysfunction, neurodegenerative diseases, and aging | Q35293165 | ||
| CSF markers for incipient Alzheimer's disease | Q35541472 | ||
| Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease | Q35563013 | ||
| The epidemiology of age-related macular degeneration | Q35688105 | ||
| Up-regulated production and activation of the complement system in Alzheimer's disease brain | Q35786312 | ||
| Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. | Q36861179 | ||
| Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature | Q36948436 | ||
| Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease | Q36968718 | ||
| Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. | Q37060457 | ||
| The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited | Q37644606 | ||
| Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration | Q37780128 | ||
| Ophthalmologic manifestations of Alzheimer's disease | Q38702937 | ||
| Psychophysical evidence for separate channels for the perception of form, color, movement, and depth | Q39680135 | ||
| Genetic association of apolipoprotein E with age-related macular degeneration | Q41866150 | ||
| Visual dysfunction in Alzheimer's disease: relation to normal aging | Q41870493 | ||
| Morphological and functional retinal impairment in Alzheimer's disease patients | Q43762429 | ||
| High occurrence rate of glaucoma among patients with Alzheimer's disease | Q43822330 | ||
| A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. | Q44286413 | ||
| Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens | Q44436553 | ||
| Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. | Q44452088 | ||
| Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease | Q44555444 | ||
| Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina | Q44607138 | ||
| Expression of apoptosis markers in the retinas of human subjects with diabetes | Q44995675 | ||
| Retinal ganglion cell degeneration in Alzheimer's disease | Q45168811 | ||
| Optic nerve head and nerve fiber layer in Alzheimer's disease | Q45282825 | ||
| Depth perception in Alzheimer's disease. | Q45968688 | ||
| Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. | Q46006000 | ||
| Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? | Q46418403 | ||
| Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases | Q46444429 | ||
| Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). | Q46650099 | ||
| CSF biomarker levels in early and late onset Alzheimer's disease | Q46652052 | ||
| Optic nerve damage in Alzheimer's disease | Q46749471 | ||
| Retinal tau pathology in human glaucomas | Q46792086 | ||
| Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study | Q46811103 | ||
| Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study | Q46889771 | ||
| Pupil reaction to light in Alzheimer's disease: evaluation of pupil size changes and mobility | Q47261022 | ||
| The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration | Q47690248 | ||
| Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide | Q47744250 | ||
| CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study | Q48381623 | ||
| Functional magnetic resonance imaging in acute unilateral optic neuritis | Q48468276 | ||
| Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma | Q48701835 | ||
| Diminished glucose transport in Alzheimer's disease: dynamic PET studies | Q48783668 | ||
| Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study | Q48874950 | ||
| Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study | Q49090173 | ||
| The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. | Q50901177 | ||
| Familial aggregation of age-related maculopathy. | Q50951242 | ||
| Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. | Q51920606 | ||
| Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. | Q52201952 | ||
| Assessment of visual impairment in patients with Alzheimer's disease. | Q53194052 | ||
| Optic-nerve degeneration in Alzheimer's disease. | Q53194632 | ||
| Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. | Q53200377 | ||
| Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders. | Q53214520 | ||
| Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. | Q53217139 | ||
| Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report. | Q53235320 | ||
| Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. | Q53237812 | ||
| Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. | Q53248123 | ||
| A potential noninvasive neurobiological test for Alzheimer's disease. | Q53315154 | ||
| Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. | Q53872892 | ||
| Electroretinographic responses and retrograde changes of retinal morphology after intracranial optic nerve section. A quantitative analysis in the cat | Q70586678 | ||
| Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina | Q72410730 | ||
| Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma | Q73559509 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 885-892 | |
| P577 | publication date | 2014-05-15 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Interconnection between brain and retinal neurodegenerations | |
| P478 | volume | 51 |
| Q35668532 | Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study |
| Q26739839 | Amyloidosis in Retinal Neurodegenerative Diseases |
| Q91635376 | Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues |
| Q47315641 | Can the retina be used to diagnose and plot the progression of Alzheimer's disease? |
| Q47158889 | Cerebral and Retinal Neurovascular Changes: A Biomarker for Alzheimer's Disease |
| Q26752575 | Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma |
| Q90375214 | Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study |
| Q88707780 | Functional optical coherence tomography of neurovascular coupling interactions in the retina |
| Q92301941 | GSK-3 Inhibitors: From the Brain to the Retina and Back Again |
| Q54975267 | Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa. |
| Q94450771 | Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study |
| Q47322741 | Optical coherence tomography indices of structural retinal pathology in schizophrenia |
| Q36257802 | Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa. |
| Q53406097 | Sub-topographic maps for regionally enhanced analysis of visual space in the mouse retina. |
| Q58567916 | Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview |
| Q37687249 | Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush |
Search more.